 Karl Bayer
Concepts (308)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 70 | 2025 | 185 | 21.660 |
Why?
| | Long-Term Potentiation | 24 | 2025 | 196 | 8.750 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 25 | 2025 | 211 | 6.080 |
Why?
| | Hippocampus | 32 | 2025 | 871 | 4.340 |
Why?
| | Long-Term Synaptic Depression | 9 | 2023 | 56 | 3.480 |
Why?
| | Synapses | 17 | 2024 | 396 | 3.330 |
Why?
| | Phosphorylation | 39 | 2025 | 1710 | 2.900 |
Why?
| | Memory | 6 | 2024 | 255 | 2.750 |
Why?
| | Calcium | 21 | 2024 | 1212 | 2.560 |
Why?
| | Neuronal Plasticity | 9 | 2025 | 279 | 2.060 |
Why?
| | Neurons | 23 | 2025 | 1494 | 2.050 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinases | 14 | 2011 | 181 | 1.980 |
Why?
| | Death-Associated Protein Kinases | 3 | 2021 | 11 | 1.950 |
Why?
| | Glutamic Acid | 9 | 2023 | 235 | 1.840 |
Why?
| | Brain Ischemia | 3 | 2025 | 321 | 1.610 |
Why?
| | Calmodulin | 10 | 2019 | 76 | 1.460 |
Why?
| | Neuroprotective Agents | 4 | 2025 | 122 | 1.430 |
Why?
| | Animals | 64 | 2025 | 35309 | 1.320 |
Why?
| | Rats | 34 | 2025 | 5482 | 1.310 |
Why?
| | Heart Arrest | 3 | 2021 | 320 | 1.180 |
Why?
| | Protein Binding | 19 | 2025 | 2120 | 1.140 |
Why?
| | Dendritic Spines | 4 | 2024 | 64 | 1.080 |
Why?
| | Amyloid beta-Peptides | 3 | 2025 | 211 | 1.050 |
Why?
| | Cell Death | 5 | 2021 | 354 | 1.010 |
Why?
| | Ischemia | 3 | 2020 | 406 | 0.970 |
Why?
| | HEK293 Cells | 9 | 2025 | 696 | 0.970 |
Why?
| | Cyclopentanes | 1 | 2025 | 19 | 0.950 |
Why?
| | Receptors, Metabotropic Glutamate | 2 | 2022 | 41 | 0.870 |
Why?
| | Learning | 2 | 2024 | 401 | 0.840 |
Why?
| | Rats, Sprague-Dawley | 17 | 2020 | 2396 | 0.820 |
Why?
| | Amino Acid Sequence | 14 | 2019 | 2056 | 0.800 |
Why?
| | Alzheimer Disease | 3 | 2025 | 514 | 0.760 |
Why?
| | Mice | 21 | 2024 | 16915 | 0.750 |
Why?
| | Protein Processing, Post-Translational | 4 | 2019 | 454 | 0.750 |
Why?
| | Electrophysiological Phenomena | 1 | 2021 | 54 | 0.710 |
Why?
| | Protein Kinase Inhibitors | 8 | 2018 | 890 | 0.700 |
Why?
| | CA1 Region, Hippocampal | 1 | 2021 | 51 | 0.700 |
Why?
| | Alternative Splicing | 5 | 2006 | 216 | 0.690 |
Why?
| | N-Methylaspartate | 9 | 2022 | 39 | 0.670 |
Why?
| | Holoenzymes | 2 | 2021 | 22 | 0.640 |
Why?
| | Disks Large Homolog 4 Protein | 1 | 2019 | 17 | 0.640 |
Why?
| | Nitric Oxide | 2 | 2014 | 901 | 0.620 |
Why?
| | Mutation | 9 | 2020 | 3710 | 0.620 |
Why?
| | Cerebral Cortex | 3 | 2021 | 436 | 0.620 |
Why?
| | Brain | 7 | 2019 | 2669 | 0.610 |
Why?
| | Peptides | 6 | 2023 | 923 | 0.610 |
Why?
| | Post-Synaptic Density | 6 | 2016 | 12 | 0.600 |
Why?
| | Cells, Cultured | 13 | 2021 | 4077 | 0.580 |
Why?
| | Lipoylation | 1 | 2017 | 17 | 0.570 |
Why?
| | Green Fluorescent Proteins | 6 | 2025 | 385 | 0.560 |
Why?
| | Synaptic Transmission | 3 | 2019 | 272 | 0.550 |
Why?
| | Molecular Sequence Data | 12 | 2014 | 2835 | 0.550 |
Why?
| | Adenosine Diphosphate | 3 | 2015 | 80 | 0.550 |
Why?
| | Protein Transport | 8 | 2019 | 428 | 0.550 |
Why?
| | A Kinase Anchor Proteins | 1 | 2017 | 71 | 0.540 |
Why?
| | Excitatory Amino Acid Agonists | 3 | 2014 | 40 | 0.530 |
Why?
| | Spine | 1 | 2017 | 157 | 0.510 |
Why?
| | Adenosine Triphosphate | 4 | 2013 | 478 | 0.510 |
Why?
| | Microscopy, Fluorescence | 3 | 2015 | 398 | 0.470 |
Why?
| | Models, Molecular | 8 | 2019 | 1487 | 0.450 |
Why?
| | Second Messenger Systems | 1 | 2014 | 33 | 0.450 |
Why?
| | Protein Conformation | 7 | 2021 | 861 | 0.430 |
Why?
| | Carrier Proteins | 6 | 2016 | 742 | 0.420 |
Why?
| | Membrane Proteins | 1 | 2019 | 1117 | 0.400 |
Why?
| | Mice, Inbred C57BL | 7 | 2024 | 5439 | 0.400 |
Why?
| | Protein Interaction Mapping | 2 | 2019 | 108 | 0.390 |
Why?
| | Actin Cytoskeleton | 3 | 2016 | 104 | 0.390 |
Why?
| | Protein Isoforms | 4 | 2018 | 389 | 0.370 |
Why?
| | Humans | 32 | 2025 | 129271 | 0.370 |
Why?
| | Autophagy | 1 | 2014 | 266 | 0.360 |
Why?
| | Drug Design | 1 | 2011 | 156 | 0.350 |
Why?
| | Nucleotides | 1 | 2011 | 122 | 0.350 |
Why?
| | Actins | 4 | 2016 | 411 | 0.340 |
Why?
| | Receptors, AMPA | 3 | 2024 | 141 | 0.340 |
Why?
| | Transfection | 5 | 2017 | 915 | 0.340 |
Why?
| | Nerve Tissue Proteins | 4 | 2019 | 569 | 0.340 |
Why?
| | Substrate Specificity | 4 | 2014 | 368 | 0.340 |
Why?
| | Protein Domains | 4 | 2019 | 253 | 0.340 |
Why?
| | Peptide Fragments | 4 | 2018 | 692 | 0.320 |
Why?
| | Cell Line | 8 | 2011 | 2779 | 0.310 |
Why?
| | Isoenzymes | 5 | 2014 | 302 | 0.310 |
Why?
| | Gene Expression Regulation, Enzymologic | 4 | 2018 | 286 | 0.310 |
Why?
| | Mice, Knockout | 3 | 2021 | 2871 | 0.310 |
Why?
| | Neuroprotection | 2 | 2020 | 38 | 0.300 |
Why?
| | Benzylamines | 5 | 2013 | 41 | 0.270 |
Why?
| | Cell Nucleus | 3 | 2012 | 586 | 0.270 |
Why?
| | Excitatory Postsynaptic Potentials | 2 | 2016 | 119 | 0.230 |
Why?
| | Enzyme Activation | 6 | 2017 | 812 | 0.230 |
Why?
| | Biological Products | 1 | 2007 | 200 | 0.220 |
Why?
| | Ionomycin | 2 | 2019 | 25 | 0.220 |
Why?
| | Binding Sites | 4 | 2014 | 1250 | 0.220 |
Why?
| | Protein Kinases | 1 | 2006 | 318 | 0.220 |
Why?
| | Signal Transduction | 7 | 2014 | 4926 | 0.220 |
Why?
| | D-Aspartic Acid | 1 | 2023 | 2 | 0.210 |
Why?
| | Male | 16 | 2024 | 63517 | 0.210 |
Why?
| | Sarcoplasmic Reticulum | 2 | 2003 | 45 | 0.200 |
Why?
| | Sulfonamides | 5 | 2013 | 495 | 0.200 |
Why?
| | Receptors, Adrenergic, beta | 1 | 2023 | 127 | 0.200 |
Why?
| | Optogenetics | 1 | 2023 | 112 | 0.190 |
Why?
| | Nucleus Accumbens | 2 | 2013 | 126 | 0.190 |
Why?
| | Cell Hypoxia | 2 | 2015 | 235 | 0.190 |
Why?
| | Protein Subunits | 2 | 2013 | 234 | 0.180 |
Why?
| | Embryo, Mammalian | 2 | 2015 | 224 | 0.170 |
Why?
| | Single Molecule Imaging | 2 | 2021 | 35 | 0.170 |
Why?
| | Animals, Newborn | 3 | 2014 | 834 | 0.170 |
Why?
| | Swine | 1 | 2023 | 760 | 0.170 |
Why?
| | Neural Inhibition | 2 | 2012 | 158 | 0.170 |
Why?
| | Spodoptera | 3 | 2009 | 37 | 0.170 |
Why?
| | Neurotoxins | 1 | 2020 | 28 | 0.170 |
Why?
| | Enzyme Inhibitors | 6 | 2015 | 827 | 0.170 |
Why?
| | Point Mutation | 2 | 2014 | 224 | 0.160 |
Why?
| | Action Potentials | 2 | 2014 | 485 | 0.160 |
Why?
| | Protective Agents | 1 | 2019 | 39 | 0.160 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2006 | 820 | 0.160 |
Why?
| | Recombinant Fusion Proteins | 3 | 2010 | 648 | 0.160 |
Why?
| | Female | 8 | 2021 | 68556 | 0.160 |
Why?
| | Protein Structure, Tertiary | 2 | 2014 | 841 | 0.160 |
Why?
| | Nervous System | 1 | 1999 | 67 | 0.150 |
Why?
| | Purkinje Cells | 1 | 2019 | 71 | 0.150 |
Why?
| | RNA, Messenger | 3 | 2018 | 2703 | 0.150 |
Why?
| | Multigene Family | 1 | 2019 | 199 | 0.150 |
Why?
| | Mutation, Missense | 2 | 2014 | 317 | 0.150 |
Why?
| | Mutagenesis | 2 | 2011 | 181 | 0.150 |
Why?
| | Movement | 1 | 2020 | 269 | 0.150 |
Why?
| | Resuscitation | 1 | 2020 | 236 | 0.140 |
Why?
| | Kinetics | 2 | 2011 | 1644 | 0.140 |
Why?
| | Exons | 1 | 2018 | 341 | 0.130 |
Why?
| | Blotting, Western | 3 | 2009 | 1204 | 0.130 |
Why?
| | Membrane Potentials | 2 | 2014 | 293 | 0.130 |
Why?
| | Organ Culture Techniques | 1 | 2016 | 153 | 0.130 |
Why?
| | Proteins | 1 | 2001 | 941 | 0.120 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 297 | 0.120 |
Why?
| | Dose-Response Relationship, Drug | 5 | 2013 | 2011 | 0.120 |
Why?
| | Miniature Postsynaptic Potentials | 1 | 2014 | 9 | 0.110 |
Why?
| | Ubiquitin-Specific Proteases | 1 | 2014 | 9 | 0.110 |
Why?
| | COS Cells | 2 | 2006 | 186 | 0.110 |
Why?
| | Pepstatins | 1 | 2014 | 4 | 0.110 |
Why?
| | I-kappa B Kinase | 1 | 2014 | 54 | 0.110 |
Why?
| | Pregnancy | 2 | 2018 | 6391 | 0.110 |
Why?
| | Sequestosome-1 Protein | 1 | 2014 | 13 | 0.110 |
Why?
| | Electrical Synapses | 1 | 2014 | 11 | 0.110 |
Why?
| | Serum Albumin, Bovine | 1 | 2014 | 63 | 0.110 |
Why?
| | Ubiquitin Thiolesterase | 1 | 2014 | 42 | 0.110 |
Why?
| | Phosphoserine | 1 | 2014 | 34 | 0.110 |
Why?
| | Muramidase | 1 | 2014 | 77 | 0.110 |
Why?
| | RNA Interference | 2 | 2014 | 450 | 0.110 |
Why?
| | RNA, Small Interfering | 2 | 2014 | 591 | 0.110 |
Why?
| | Staurosporine | 1 | 2013 | 20 | 0.110 |
Why?
| | 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine | 1 | 2013 | 28 | 0.110 |
Why?
| | Gap Junctions | 1 | 2014 | 61 | 0.110 |
Why?
| | Genes, Reporter | 1 | 2014 | 265 | 0.110 |
Why?
| | Extracellular Signal-Regulated MAP Kinases | 2 | 2014 | 169 | 0.110 |
Why?
| | Disease Models, Animal | 2 | 2021 | 4057 | 0.100 |
Why?
| | Leucine | 1 | 2014 | 108 | 0.100 |
Why?
| | GTPase-Activating Proteins | 1 | 2013 | 81 | 0.100 |
Why?
| | Protease Inhibitors | 1 | 2014 | 106 | 0.100 |
Why?
| | Heat-Shock Proteins | 1 | 2014 | 136 | 0.100 |
Why?
| | Ventral Tegmental Area | 1 | 2013 | 52 | 0.100 |
Why?
| | Ubiquitin-Protein Ligases | 1 | 2014 | 154 | 0.100 |
Why?
| | Statistics, Nonparametric | 1 | 2014 | 420 | 0.100 |
Why?
| | Myosin Type I | 1 | 2012 | 1 | 0.100 |
Why?
| | Cytoplasmic Vesicles | 1 | 2012 | 13 | 0.100 |
Why?
| | Amphetamine-Related Disorders | 1 | 2013 | 36 | 0.100 |
Why?
| | Glucose Transporter Type 4 | 1 | 2012 | 39 | 0.100 |
Why?
| | Microtubule-Associated Proteins | 1 | 2014 | 192 | 0.100 |
Why?
| | Cell Line, Transformed | 1 | 2012 | 140 | 0.100 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 1 | 1 | 2011 | 3 | 0.100 |
Why?
| | Cocaine | 1 | 2013 | 149 | 0.090 |
Why?
| | Cognition | 1 | 2019 | 1122 | 0.090 |
Why?
| | Tumor Suppressor Proteins | 1 | 2014 | 314 | 0.090 |
Why?
| | Base Sequence | 3 | 2002 | 2146 | 0.090 |
Why?
| | Solutions | 1 | 2011 | 150 | 0.090 |
Why?
| | Mice, Transgenic | 1 | 2016 | 2117 | 0.090 |
Why?
| | Serine | 1 | 2011 | 138 | 0.090 |
Why?
| | Oxidation-Reduction | 1 | 2014 | 1028 | 0.090 |
Why?
| | Alanine | 1 | 2011 | 142 | 0.090 |
Why?
| | Muscle, Skeletal | 2 | 2003 | 1613 | 0.090 |
Why?
| | Seizures | 1 | 2014 | 401 | 0.090 |
Why?
| | Viral Fusion Proteins | 1 | 2010 | 18 | 0.090 |
Why?
| | Gene Products, tat | 1 | 2010 | 21 | 0.090 |
Why?
| | PC12 Cells | 1 | 2010 | 37 | 0.090 |
Why?
| | Cell-Penetrating Peptides | 1 | 2010 | 21 | 0.080 |
Why?
| | Receptors, Adrenergic, alpha-1 | 1 | 2010 | 43 | 0.080 |
Why?
| | Insulin | 2 | 2012 | 2325 | 0.080 |
Why?
| | Electric Stimulation | 1 | 2010 | 269 | 0.080 |
Why?
| | Conditioning, Classical | 1 | 2010 | 116 | 0.080 |
Why?
| | Patch-Clamp Techniques | 1 | 2010 | 279 | 0.080 |
Why?
| | Immunohistochemistry | 5 | 2013 | 1691 | 0.080 |
Why?
| | Cell Membrane | 1 | 2012 | 733 | 0.080 |
Why?
| | Rats, Wistar | 2 | 2007 | 441 | 0.080 |
Why?
| | In Vitro Techniques | 1 | 2010 | 1085 | 0.070 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2009 | 541 | 0.070 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2010 | 259 | 0.070 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2010 | 443 | 0.070 |
Why?
| | Behavior, Animal | 1 | 2010 | 506 | 0.070 |
Why?
| | Gene Expression | 2 | 2006 | 1466 | 0.070 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2006 | 4 | 0.070 |
Why?
| | Mutant Proteins | 1 | 2006 | 99 | 0.060 |
Why?
| | 2-Amino-5-phosphonovalerate | 1 | 2006 | 12 | 0.060 |
Why?
| | Trinucleotide Repeats | 1 | 2006 | 25 | 0.060 |
Why?
| | Subcellular Fractions | 1 | 2006 | 80 | 0.060 |
Why?
| | Chickens | 1 | 2006 | 189 | 0.060 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2006 | 100 | 0.060 |
Why?
| | Models, Biological | 3 | 2003 | 1722 | 0.060 |
Why?
| | Glycine | 1 | 2006 | 165 | 0.060 |
Why?
| | Amino Acid Substitution | 1 | 2006 | 282 | 0.060 |
Why?
| | Immunoblotting | 3 | 2013 | 305 | 0.060 |
Why?
| | alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid | 2 | 2014 | 15 | 0.060 |
Why?
| | Proto-Oncogene Proteins c-raf | 1 | 2003 | 45 | 0.050 |
Why?
| | Neurites | 1 | 2003 | 45 | 0.050 |
Why?
| | Integrins | 1 | 2003 | 94 | 0.050 |
Why?
| | Actinin | 1 | 2002 | 13 | 0.050 |
Why?
| | Immunoprecipitation | 2 | 2014 | 157 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinases | 1 | 2003 | 311 | 0.050 |
Why?
| | Stroke | 1 | 2010 | 1070 | 0.050 |
Why?
| | Cloning, Molecular | 1 | 2002 | 525 | 0.050 |
Why?
| | Islets of Langerhans | 1 | 2007 | 789 | 0.050 |
Why?
| | Kidney | 2 | 2006 | 1385 | 0.040 |
Why?
| | Cytoskeleton | 1 | 2001 | 183 | 0.040 |
Why?
| | Ganglia | 1 | 1999 | 17 | 0.040 |
Why?
| | Gene Expression Profiling | 1 | 2006 | 1688 | 0.040 |
Why?
| | Enzyme Induction | 1 | 1999 | 90 | 0.040 |
Why?
| | Prostatic Neoplasms | 1 | 2007 | 1016 | 0.040 |
Why?
| | Microsomes | 1 | 1998 | 35 | 0.040 |
Why?
| | Cell Compartmentation | 1 | 1998 | 52 | 0.040 |
Why?
| | Organ Specificity | 1 | 1999 | 295 | 0.040 |
Why?
| | Head | 1 | 1999 | 96 | 0.040 |
Why?
| | Enzymes, Immobilized | 1 | 1998 | 29 | 0.040 |
Why?
| | Amyloid beta-Protein Precursor | 1 | 2018 | 61 | 0.040 |
Why?
| | Apoptosis | 1 | 2007 | 2499 | 0.040 |
Why?
| | Biological Transport | 1 | 1998 | 404 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2019 | 250 | 0.030 |
Why?
| | Spinal Cord | 1 | 1999 | 353 | 0.030 |
Why?
| | Microscopy, Electron | 1 | 2017 | 426 | 0.030 |
Why?
| | Microscopy, Immunoelectron | 1 | 2016 | 42 | 0.030 |
Why?
| | Pseudopodia | 1 | 2016 | 25 | 0.030 |
Why?
| | Protein Multimerization | 1 | 2017 | 178 | 0.030 |
Why?
| | Microscopy, Confocal | 2 | 2010 | 305 | 0.030 |
Why?
| | Fluorescence Resonance Energy Transfer | 1 | 2017 | 175 | 0.030 |
Why?
| | Sarcomeres | 1 | 1996 | 92 | 0.030 |
Why?
| | DNA, Complementary | 1 | 1996 | 271 | 0.030 |
Why?
| | DNA Primers | 1 | 1996 | 510 | 0.030 |
Why?
| | Ribosomal Protein S6 Kinases | 1 | 2014 | 21 | 0.030 |
Why?
| | Deubiquitinating Enzyme CYLD | 1 | 2014 | 3 | 0.030 |
Why?
| | Polyubiquitin | 1 | 2014 | 7 | 0.030 |
Why?
| | Kainic Acid | 1 | 2014 | 34 | 0.030 |
Why?
| | Muscle Proteins | 1 | 1996 | 220 | 0.030 |
Why?
| | Ion Transport | 1 | 2014 | 62 | 0.030 |
Why?
| | Tissue Culture Techniques | 1 | 2014 | 74 | 0.030 |
Why?
| | Synaptic Membranes | 1 | 2013 | 17 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2014 | 148 | 0.030 |
Why?
| | Cell Fractionation | 2 | 2003 | 56 | 0.030 |
Why?
| | Dopamine Uptake Inhibitors | 1 | 2013 | 55 | 0.030 |
Why?
| | Polyribosomes | 1 | 2013 | 21 | 0.030 |
Why?
| | Conditioning, Operant | 1 | 2013 | 104 | 0.030 |
Why?
| | Amphetamine | 1 | 2013 | 25 | 0.030 |
Why?
| | Calcium Channels, L-Type | 1 | 2014 | 117 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 1996 | 1247 | 0.030 |
Why?
| | Time Factors | 3 | 2013 | 6543 | 0.030 |
Why?
| | Rats, Long-Evans | 1 | 2013 | 136 | 0.020 |
Why?
| | Potassium | 1 | 2013 | 143 | 0.020 |
Why?
| | Dendrites | 1 | 2013 | 98 | 0.020 |
Why?
| | MAP Kinase Signaling System | 1 | 2014 | 313 | 0.020 |
Why?
| | Exocytosis | 1 | 2012 | 88 | 0.020 |
Why?
| | Cytosol | 1 | 2012 | 219 | 0.020 |
Why?
| | Calcium-Binding Proteins | 1 | 2013 | 211 | 0.020 |
Why?
| | Neural Pathways | 1 | 2013 | 302 | 0.020 |
Why?
| | Drug Interactions | 1 | 2013 | 393 | 0.020 |
Why?
| | Lysine | 1 | 2014 | 286 | 0.020 |
Why?
| | Drug Administration Schedule | 1 | 2013 | 768 | 0.020 |
Why?
| | Endocytosis | 1 | 2012 | 163 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2012 | 316 | 0.020 |
Why?
| | Central Nervous System Stimulants | 1 | 2013 | 154 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 1996 | 1204 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2014 | 396 | 0.020 |
Why?
| | Up-Regulation | 1 | 2014 | 839 | 0.020 |
Why?
| | Liver | 1 | 1999 | 1839 | 0.020 |
Why?
| | Adrenergic alpha-1 Receptor Agonists | 1 | 2010 | 2 | 0.020 |
Why?
| | Phenylephrine | 1 | 2010 | 75 | 0.020 |
Why?
| | Calcineurin | 1 | 2010 | 98 | 0.020 |
Why?
| | Receptors, GABA-A | 1 | 2010 | 126 | 0.020 |
Why?
| | Thapsigargin | 1 | 2007 | 19 | 0.020 |
Why?
| | TNF-Related Apoptosis-Inducing Ligand | 1 | 2007 | 44 | 0.020 |
Why?
| | Androgen Receptor Antagonists | 1 | 2007 | 36 | 0.020 |
Why?
| | Luciferases | 1 | 2007 | 147 | 0.020 |
Why?
| | Androstadienes | 1 | 2007 | 106 | 0.020 |
Why?
| | Antibiotics, Antineoplastic | 1 | 2007 | 123 | 0.020 |
Why?
| | Image Processing, Computer-Assisted | 1 | 2010 | 742 | 0.020 |
Why?
| | Prostate-Specific Antigen | 1 | 2007 | 162 | 0.020 |
Why?
| | Receptors, Androgen | 1 | 2007 | 147 | 0.020 |
Why?
| | Androgens | 1 | 2007 | 178 | 0.020 |
Why?
| | Doxorubicin | 1 | 2007 | 328 | 0.010 |
Why?
| | Tumor Cells, Cultured | 1 | 2007 | 942 | 0.010 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2007 | 360 | 0.010 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 947 | 0.010 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2007 | 431 | 0.010 |
Why?
| | Drug Therapy, Combination | 1 | 2007 | 1040 | 0.010 |
Why?
| | Precipitin Tests | 1 | 2003 | 97 | 0.010 |
Why?
| | Isoquinolines | 1 | 2003 | 41 | 0.010 |
Why?
| | Organisms, Genetically Modified | 1 | 2003 | 14 | 0.010 |
Why?
| | Fibronectins | 1 | 2003 | 123 | 0.010 |
Why?
| | ras Proteins | 1 | 2003 | 144 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2010 | 2375 | 0.010 |
Why?
| | Luminescent Proteins | 1 | 2003 | 174 | 0.010 |
Why?
| | Immunosuppressive Agents | 1 | 2007 | 854 | 0.010 |
Why?
| | HeLa Cells | 1 | 2003 | 611 | 0.010 |
Why?
| | Cell Movement | 1 | 2003 | 944 | 0.010 |
Why?
| | Bacterial Proteins | 1 | 2003 | 833 | 0.010 |
Why?
|
|
Bayer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|